Skip to content

Mehmet Sofuoglu

5 papers in the library · 10 citations · publishing 2011-2024

Papers

Sort Most recent Most cited

From taboo to treatment: The emergence of psychedelics in the management of pain and opioid use disorder.

British Journal of Clinical Pharmacology December 1, 2024 Jeremy Weleff, Julio C Nunes, Gabriel P. A. Costa et al. 8 citations

The rise of psychedelics in contemporary medicine has sparked interest in their potential therapeutic applications. While traditionally associated with countercultural movements and recreational use, recent research has shed light on the potential benefits of psychedelics in various mental health conditions. In this review, we explore the possible role of psychedelics in the management of...

DOI: 10.1111/bcp.16045 (opens in new tab) Full text (opens in new tab) Analgesia Drug development Hallucinogen Nociception +1

A preliminary investigation of the acute effects of delta-9-tetrahydrocannabinol on pain and opioid attentional bias among persons with opioid use disorder.

Journal of Psychiatric Research September 1, 2024 Noah R Wolkowicz, Mehmet Sofuoglu, Brian Pittman et al.

Attentional bias (AB) is believed to be an important factor in the development and maintenance of both opioid use disorder (OUD) and chronic pain. Cannabis and its main psychoactive constituent, delta-9-tetrahydrocannabinol (THC), produce analgesic effects via processes that are potentially relevant to AB and is commonly used by persons with OUD. This exploratory study investigated if THC...

Brief report: The influence of childhood trauma on the effects of delta-9-tetrahydrocannabinol in persons with opioid use disorder.

American Journal on Addictions May 1, 2024 Michael Rogan, Julio C Nunes, Catherine Z Xie et al. 2 citations

Childhood trauma (CT) increases addiction vulnerability. We examined CT's impact on delta-9-tetrahydrocannabinol (THC) effects. This is a post-hoc analysis of a randomized, placebo-controlled, crossover trial investigating the effects of oral THC (10, 20 mg) among 25 persons receiving methadone for opioid use disorder (OUD). Greater CT was associated with lower aversive effects from higher THC...

From Taboo to Treatment: The Emergence of Psychedelics in the Management of Pain and Opioid Use Disorder

October 30, 2023 Jeremy Weleff, Julio C Nunes, Gabriel P. A. Costa et al.

The rise of psychedelics in contemporary medicine has sparked interest in their potential therapeutic applications. While traditionally associated with countercultural movements and recreational use, recent research has shed light on the potential benefits of psychedelics in various mental health conditions. In this review, we explore the emerging role of psychedelics in the management of...

The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans.

Pharmacology, Biochemistry, and Behavior March 2011 Dawn E Sugarman, James Poling, Mehmet Sofuoglu

Marijuana (cannabis) is the most widely used illicit substance globally, and cannabis use is associated with a range of adverse consequences. Currently, no medications have been proven to be effective for the treatment of cannabis addiction. The goals of this study were to examine the safety and efficacy of a potential treatment medication, modafinil, in combination with oral...